SCHEMBL29015652

SCHEMBL29015652

COC(=O)c1cc2c(OS(C)(=O)=O)cccc2[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 2/20 0.49
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
RCE1 Q9Y256 1/20 0.46
ULK1 O75385 1/20 0.46
KDM4E B2RXH2 4/20 0.46
MAPT P10636 3/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPC1 O15118 1/20 0.46
POLB P06746 1/20 0.46
HRH4 Q9H3N8 1/20 0.45
NR4A2 P43354 1/20 0.43
SRD5A2 P31213 1/20 0.43
IDO1 P14902 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29015429 0.86 SRD5A2 (0.58) FLT3GLAGAAKMT2AMEN1
SCHEMBL217459 0.84 FLT3 (0.66) FLT3GLAGAAKMT2AMEN1
SCHEMBL24189784 0.81 NR4A2 (0.46) FLT3GLAGAAKMT2AMEN1
SCHEMBL6308070 0.81 FLT3 (0.51) FLT3GLAGAAKMT2AMEN1
SCHEMBL914150 0.80 ULK1 (0.67) FLT3GLAGAAKMT2AMEN1
SCHEMBL7044742 0.80 SRD5A2 (0.53) FLT3GLAGAAKMT2AMEN1
SCHEMBL22235474 0.78 FLT3 (0.52) FLT3GLAGAAKMT2AMEN1
SCHEMBL31158902 0.78 FLT3 (0.49) FLT3GLAGAAKMT2AMEN1
SCHEMBL30396582 0.78 XDH (0.59) FLT3GLAGAAKMT2AMEN1
SCHEMBL30397530 0.77 KDM4E (0.46) FLT3GLAGAAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096714-A Antiviral compounds for the treatment of coronavirus, picornavirus and norovirus infections 安力高医药股份有限公司 2023-05-09 CN disclosed
EP-4165037-A1 ANTI-VIRAL COMPOUNDS FOR TREATING CORONAVIRUS, PICORNAVIRUS, AND NOROVIRUS INFECTIONS Aligos Therapeutics, Inc. (US) 2023-04-19 EP disclosed